Ursula von der Leyen (second right) speaks with Pfizer CEO Albert Bourla (left), Belgium Prime Minister Alexander De Croo (second left) and BioNTech's Özlem Türeci during an official visit to the Pfizer pharmaceutical company in Puurs, Belgium (John Thys/Pool via AP Images)
June 29, 2022 12:37 PM EDTUpdated July 1, 12:44 PM
Pharma
Coronavirus

Eu­ro­pean Com­mis­sion says it does­n't have texts be­tween pres­i­dent Ur­su­la von der Leyen and Pfiz­er CEO Al­bert Bourla

Nicole DeFeudis

Editor

Un­der fire from the Eu­ro­pean om­buds­man, the Com­mis­sion said on Wednes­day that it hasn’t found any text mes­sages be­tween pres­i­dent Ur­su­la von der Leyen and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times